Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001

التفاصيل البيبلوغرافية
العنوان:	Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001
المؤلفون:	Bernhard, J, Dietrich, D, Scheithauer, W, Gerber, D, Bodoky, GR, Ruhstaller, T, Glimelius, B, Bajetta, E, Schuller, J, Saletti, P, Bauer, J, Figer, A, Pestalozzi, BC, Hne, CHK, Mingrone, W, Stemmer, SM, Tamas, K, Kornek, GV, Koeberle, D, Herrmann, R
المصدر:	Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(22):3695-3701
مصطلحات موضوعية:	Medicin och hälsovetenskap
URL الوصول:	http://kipublications.ki.se/Default.aspx?queryparsed=id:117378859
قاعدة البيانات:	SwePub

الوصف
تدمد:	15277755
DOI:	10.1200/JCO.2007.15.6240